Format

Send to

Choose Destination
Pediatrician. 1991;18(1):49-52.

Delayed cardiac toxicity from anthracycline therapy.

Author information

1
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, N.Y.

Abstract

Survivors of childhood cancer who received anthracycline treatment have a high incidence of abnormal cardiac function. Cardiac decompensation and death can appear many years after completion of chemotherapy. These survivors require periodic evaluation of cardiac function and rhythm.

PMID:
1983861
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center